ENG/中
老虎证券
市场
行情
24/7新闻
产品
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
基因编辑
341.43
+1.47
0.43%
涨家数:
2
跌家数:
2
平家数:
- -
市盈率:
- -
高:
362.46
开:
340.15
低:
340.15
收:
339.96
成交量:
1,807.14万
成交额:
3.41亿
市值:
76.97亿
流通市值:
72.60亿
数据加载中...
总览
新闻资讯
动物实验显示:CRISPR疗法实现一次输注三年控脂
格隆汇
·
11/17
Seawolf Therapeutics完成A轮融资,Versant Ventures、MPM BioImpact、诺华创投基金、礼来、CRISPR Therapeutics等参投
美股速递
·
11/16
Beam Therapeutics:Beacon试验所有次要终点均达成,包括VOC相关住院豁免
美股速递
·
11/10
Beam Therapeutics:Beacon试验显示risto-cel在镰状细胞病中达到主要疗效与安全性终点
美股速递
·
11/10
Beam Therapeutics预计2026年底前向美国FDA提交Risto-Cel治疗镰状细胞病的生物制品许可申请
美股速递
·
11/03
Beam Therapeutics公布2026年第三季度财务业绩,碱基编辑产品线临床进展亮点纷呈
美股速递
·
11/03
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK4556/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4556","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","market":"US","secType":"PLATE","nameCN":"基因编辑","latestPrice":341.42886,"timestamp":1795035599999,"preClose":339.96085,"halted":0,"volume":18071403,"delay":0,"changeRate":0.004318,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":1.468018,"latestTime":"11-18 16:00:00 EST","open":340.14542,"high":362.45953,"low":340.14542,"amount":340866885.01752,"amplitude":0.065637,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1795078800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":2.32709,"peRate":-7.221676,"turnoverRate":0.04113,"increases":2,"decrements":2,"flats":0,"marketCap":7697130656,"floatMarketCap":7259926976},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","high":362.45953,"amplitude":0.065637,"preClose":339.96085,"low":340.14542,"pbRate":"2.32709","latestPrice":341.42886,"volume":18071403,"delay":0,"open":340.14542,"prevYearClose":431.70972,"prevWeekClose":360.4512,"prevMonthClose":440.4987,"prevQuarterClose":441.4069,"fiveDayClose":401.2179,"twentyDayClose":419.4862,"sixtyDayClose":508.8457,"secType":"PLATE","market":"US","turnoverRate":0.04113,"peRate":-7.221676,"marketCap":7697130656,"floatMarketCap":7259926976,"timestamp":1795035599999,"nameCN":"基因编辑"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4556\",,,,undefined,":{"bkCode":"BK4556","up":2,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4556\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2684262376","title":"动物实验显示:CRISPR疗法实现一次输注三年控脂","url":"https://stock-news.laohu8.com/highlight/detail?id=2684262376","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2684262376?lang=zh_cn&edition=fundamental","pubTime":"2026-11-17 07:07","pubTimestamp":1794870439,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1861559042.SGD","BK4588","BK4139","BK4556","LU1861558580.USD","CRSP","BK4585","SYNB","ARKG","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187133930","title":"Seawolf Therapeutics完成A轮融资,Versant Ventures、MPM BioImpact、诺华创投基金、礼来、CRISPR Therapeutics等参投","url":"https://stock-news.laohu8.com/highlight/detail?id=1187133930","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187133930?lang=zh_cn&edition=fundamental","pubTime":"2026-11-16 18:01","pubTimestamp":1794823276,"startTime":"0","endTime":"0","summary":"Seawolf Therapeutics成功完成A轮融资,本轮融资由Versant Ventures、MPM BioImpact、诺华创投基金、礼来以及CRISPR Therapeutics AG等多家机构共同参与。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4516","LU1551013425.SGD","TRUH","GDOC","GB00BDT5M118.USD","LU1974910355.USD","IE00B4JS1V06.HKD","IE00BJT1NW94.SGD","LU0820561909.HKD","LU2089283258.USD","IE00BJJMRZ35.SGD","LU1548497426.USD","SG9999014914.USD","LU2028103732.USD","LU2089284900.SGD","LU2361044865.SGD","LU2552382058.USD","LU0289739699.SGD","LU1868836591.USD","LU2896262040.SGD","IXJ","LU0256863811.USD","LU0011850046.USD","LU2746668461.USD","LU0133085943.USD","LU0823434740.USD","IE00BFSS8Q28.SGD","IE0004445015.USD","IE00B775H168.HKD","IE00BKDWB100.SGD","SG9999015945.SGD","LU0316494557.USD","LU2357305700.SGD","IE0001KFT4U8.USD","LU2213496289.HKD","LU1551013342.USD","LU0323591593.USD","IE00BK4W5L77.USD","LU1979441026.SGD","LU1983299246.USD","LU1023059063.AUD","LU2023251221.USD","LU0882574139.USD","LU0889565916.HKD","LU0061475181.USD","LU0210536198.USD","LU0097036916.USD","LU0964807845.USD","LU1127390331.HKD","LU2237443622.USD","LU2237443465.HKD","LU1712237335.SGD","LU2361044949.HKD","BK4585","LU2471134952.CNY","IE00B7KXQ091.USD","LU1232071149.USD","LU2125154935.USD","CANC","LU1061106388.HKD","CRSP","LU0432979614.USD","IE00B4R5TH58.HKD","BK4533","LU0198837287.USD","LU0672654240.SGD","LU0353189680.USD","LU2360106947.USD","LU0545039389.USD","IE00BJLML261.HKD","LU1291159041.SGD","LU1861558580.USD","LU2602419157.SGD","LU1366192091.USD","LU2112291526.USD","LLYX","LU1003077747.HKD","MEDI","LU1280957306.USD","LU1064131342.USD","LU2271345857.HKD","LU0553294199.USD","LU2324357040.USD","LU2023250504.SGD","SG9999017495.SGD","LU0823416689.USD","LU0174119429.USD","BK4599","LU2491049909.HKD","LU1093756325.SGD","IE00B1XK9C88.USD","SG9999018857.SGD","TMED","IE00B2B36J28.USD","IE0005OL40V9.USD","ILDR","LU2462157665.USD","LU0225283273.USD","LU0006306889.USD","ARKG","LU0096364046.USD","LU0158827781.USD","LU2023250330.USD","BK4139","LU0345770308.USD","BK4556","HRTS","IE00BK4W5M84.HKD","LU0058720904.USD","LU0320765992.SGD","LU2756315318.SGD","BK4007","MEDX","LU1629891620.HKD","LU2168564222.USD","LU0345770993.USD","LU2237438978.USD","LU2471134879.HKD","SG9999014880.SGD","LU2746668974.SGD","LU0385154629.USD","IE0002141913.USD","LU2756315664.SGD","IE00BJJMRY28.SGD","LLII","LU0238689110.USD","LU2491050154.USD","LU2462591350.SGD","LU0689472784.USD","LU0234572021.USD","LU0640476718.USD","SG9999013999.USD","IE00BFSS7M15.SGD","LU0787776722.HKD","LU2471134796.USD","LU1623119135.USD","LU2237443549.SGD","LU2237443978.SGD","LU0203201768.USD","BK4611","LU2108987350.USD","RXL","VHT","BK4534","BK4581","LU2111349929.HKD","LU2211817866.USD","LU0882574055.USD","LU2264538146.SGD","LU0122379950.USD","LU2360032135.SGD","LU1323610961.USD","LU2087625088.SGD","LU0417517546.SGD","LU2491050071.SGD","LU0114720955.EUR","LU1035775433.USD","SG9999001176.SGD","LU2265009873.SGD","LU1804176565.USD","LU2456880835.USD","LU0820562030.AUD","LU1093756168.USD","LU1145028129.USD","CURE","LU1153585028.USD","LU2750360641.GBP","BK4588","SGXZ99366536.SGD","SGXZ31699556.SGD","LU2237443895.HKD","ELIS","IE0009355771.USD","LU0158827948.USD","LU1057294990.SGD","FHLC","AGNG","LU0471298694.HKD","LU0708995401.HKD","LU2063271972.USD","LU0661504455.SGD","LU1720051108.HKD","IE00BKPKM429.USD","LU0949170772.SGD","LU2471134523.USD","LLYZ","LU0320765059.SGD","SG9999015986.USD","LU1069344957.HKD","LU2168564065.EUR","LU2125154778.USD","LU0354030511.USD","LU0943347566.SGD","LU0106261372.USD","LU2237443382.USD","IE00B1BXHZ80.USD","LU1267930730.SGD","THNR","LU2461242641.AUD","LU0266013472.USD","LU1868836914.USD","IE00BN29S564.USD","LU0738911758.USD","LU0786609619.USD","LU1720051017.SGD","MHIP","PJP","FTXH","IE0004445239.USD","LU1814569148.SGD","IE00BFTCPJ56.SGD","IE00BWXC8680.SGD","LU2236285917.USD","LU2468319806.SGD","SG9999015952.SGD","LU1917777945.USD","LU2417539215.USD","SG9999014898.SGD","LU0203202063.USD","LU2089984988.USD","LU2168564495.EUR","SG9999001176.USD","LU2168564149.EUR","WDNA","LU0109391861.USD","SGXZ57979304.SGD","LU1988902786.USD","JDOC","LU0354030438.USD","LU0094547139.USD","LU2361045086.USD","LU0353189763.USD","LU0456855351.SGD","LU0683600562.USD","SGXZ51526630.SGD","LU0256863902.USD","OZEM","LU2211815571.USD","LU0079474960.USD","SG9999018865.SGD","LLY","LU0466842654.USD","LU1989771016.USD","PPH","IYH","LU0471298777.SGD","SG9999015978.USD","LU0820561818.USD","LU2552382132.HKD","LU2750360997.AUD","LU1861559042.SGD","LU1868836757.USD","LU1868837136.USD","ELIL","LU0109394709.USD","LU2552382215.SGD","SG9999014906.USD","SGXZ81514606.USD","IE00BJJMRX11.SGD","IHE","LU2106854487.HKD","LU1691799644.USD","LU2168563687.JPY","LU0823434583.USD","XLV","LU1868837300.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170714716","title":"Beam Therapeutics:Beacon试验所有次要终点均达成,包括VOC相关住院豁免","url":"https://stock-news.laohu8.com/highlight/detail?id=1170714716","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170714716?lang=zh_cn&edition=fundamental","pubTime":"2026-11-10 20:02","pubTimestamp":1794312128,"startTime":"0","endTime":"0","summary":"Beam Therapeutics公司宣布,Beacon试验成功触及全部次要终点,其中涵盖血管闭塞危象(VOC)患者的免于住院这一指标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BEAM","BK4535","LU1861559042.SGD","BK4505","BK4588","BK4139","BK4556","LU1861558580.USD","BK4585","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197134313","title":"Beam Therapeutics:Beacon试验显示risto-cel在镰状细胞病中达到主要疗效与安全性终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1197134313","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197134313?lang=zh_cn&edition=fundamental","pubTime":"2026-11-10 20:01","pubTimestamp":1794312076,"startTime":"0","endTime":"0","summary":"Beam Therapeutics公司宣布,其Beacon临床试验中,risto-cel用于治疗镰状细胞病已成功达成主要疗效终点和安全性终点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4535","BK4505","BK4139","BK4611","LU1861559042.SGD","BK4556","LU1861558580.USD","BEAM","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167025040","title":"Beam Therapeutics预计2026年底前向美国FDA提交Risto-Cel治疗镰状细胞病的生物制品许可申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1167025040","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167025040?lang=zh_cn&edition=fundamental","pubTime":"2026-11-03 20:12","pubTimestamp":1793707931,"startTime":"0","endTime":"0","summary":"Beam Therapeutics, Inc. 预计将于2026年年底前,就Risto-Cel用于治疗镰状细胞病向美国监管机构递交生物制品许可申请(BLA)。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861559042.SGD","BK4556","LU1861558580.USD","BK4611","BEAM","BK4535","BK4588","BK4139","BK4505","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122751255","title":"Beam Therapeutics公布2026年第三季度财务业绩,碱基编辑产品线临床进展亮点纷呈","url":"https://stock-news.laohu8.com/highlight/detail?id=1122751255","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122751255?lang=zh_cn&edition=fundamental","pubTime":"2026-11-03 20:01","pubTimestamp":1793707280,"startTime":"0","endTime":"0","summary":"Beam Therapeutics公布2026年第三季度财务业绩,碱基编辑产品线临床进展亮点纷呈","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4535","BK4505","BK4588","LU1861558580.USD","BK4585","BK4611","LU1861559042.SGD","BK4556","BEAM"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}]}}